GraniteShares Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.02M | Sell |
2,286
-28
| -1% | -$12.5K | 0.63% | 57 |
|
|
2025
Q1 | $1.12M | Sell |
2,314
-150
| -6% | -$72.7K | 0.72% | 54 |
|
|
2024
Q4 | $992K | Sell |
2,464
-219
| -8% | -$88.2K | 0.63% | 60 |
|
|
2024
Q3 | $1.25M | Sell |
2,683
-135
| -5% | -$62.8K | 0.84% | 53 |
|
|
2024
Q2 | $1.32M | Buy |
2,818
+90
| +3% | +$42.2K | 0.44% | 54 |
|
|
2024
Q1 | $1.14M | Buy |
2,728
+16
| +0.6% | +$6.69K | 0.6% | 57 |
|
|
2023
Q4 | $1.1M | Sell |
2,712
-446
| -14% | -$181K | 0.99% | 54 |
|
|
2023
Q3 | $1.1M | Buy |
3,158
+2,406
| +320% | +$837K | 1.02% | 48 |
|
|
2023
Q2 | $265K | Sell |
752
-12
| -2% | -$4.22K | 0.24% | 90 |
|
|
2023
Q1 | $241K | Sell |
764
-12
| -2% | -$3.78K | 0.21% | 107 |
|
|
2022
Q4 | $224K | Sell |
776
-151
| -16% | -$43.6K | 0.19% | 129 |
|
|
2022
Q3 | $268K | Sell |
927
-106
| -10% | -$30.6K | 0.22% | 115 |
|
|
2022
Q2 | $291K | Sell |
1,033
-102
| -9% | -$28.7K | 0.21% | 113 |
|
|
2022
Q1 | $296K | Sell |
1,135
-100
| -8% | -$26.1K | 0.16% | 136 |
|
|
2021
Q4 | $271K | Buy |
+1,235
| New | +$271K | 0.13% | 148 |
|